Metraipolis › archive › dc_19a1ed0fee28

Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Low Breast Cancer With Cancer-Related Microangiopathic Hemolytic Anemia: A Case Report — Europe PMC PMID:41078700

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41078700
DOI
10.1002/cai2.70029
License (as archived)
solo-consultazione
Archived
2026-11-09T09:53:36.313Z
SHA-256 of the archived text
12eb8bd36e42223fc915039ef041b2a3177f6b228e8c88218c553ff998d745f2
Stable URL of this page
https://metraipolis.com/documento/dc_19a1ed0fee28

How to cite

Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Low Breast Cancer With Cancer-Related Microangiopathic Hemolytic Anemia: A Case Report — Europe PMC PMID:41078700 — Europe PMC (en), https://europepmc.org/article/MED/41078700 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_19a1ed0fee28 (Metraipolis archive dc_19a1ed0fee28, sha256 12eb8bd36e42223fc915039ef041b2a3177f6b228e8c88218c553ff998d745f2)
BibTeX
@misc{dc19a1ed0fee28,
  title = {Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Low Breast Cancer With Cancer-Related Microangiopathic Hemolytic Anemia: A Case Report — Europe PMC PMID:41078700},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41078700},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_19a1ed0fee28; sha256 12eb8bd36e42223fc915039ef041b2a3177f6b228e8c88218c553ff998d745f2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41078700. Agents can read the archived copy with the MCP tool read_document.